S&P BSE 150 Midcap Index News and Updates

Name: Latest research reports of Container Corporation of India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Container Corporation of India Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on S&P BSE 150 Midcap Index from all sources in a single place.

Load latest

Container Corporation of India Ltd.

13 Nov 2025

515.40

-0.42%

EBITDA ahead of consensus; co maintains volume growth guidance of 13% for FY26

Buy: Container Corporation of I...

ICICI Securities Limited

CONCOR’s Q2FY26 EBITDA of INR 5.7bn rose 33.4% sequentially and was ahead of consensus estimates. Overall volume rose 10.5% YoY (EXIM - 8.7% and domestic - 16.6%); rail freight margin improved to 27.8% (26.2% in H1FY25).

Number of FII/FPI investors decreased from 554 to 530 in Sep 2025 qtr

Fortis Healthcare Ltd.

13 Nov 2025

935.40

1.35%

Robust execution and network expansion to support growth

Hold: Fortis Healthcare Ltd.

Recommendation Target

ICICI Securities Limited

Fortis Healthcare (Fortis) delivered a strong beat in EBITDA and PAT led by stronger margins across its hospitals (+140bps) and diagnostic verticals (+510bps).

Fortis Healthcare Ltd. has gained 36.39% in the last 6 Months

Indian Bank

13 Nov 2025

882.35

-0.36%

Sustained focus on profitable and prudent growth

Buy: Indian Bank

Emkay

Indian Bank (INBK) continues to rank among the best performing PSBs, and our recent interaction with the MD and CEO, Binod Kumar reaffirms the bank’s firm focus on delivering sustainably higher profitability over growth.

Indian Bank has gained 44.29% in the last 6 Months

Muthoot Finance Ltd.

13 Nov 2025

3697.50

-0.11%

Shining stronger; margin expansion and recoveries lift earnings

Neutral: Muthoot Finance Ltd.

Target

Motilal Oswal

Muthoot Finance’s (MUTH) strong operating performance in 2QFY26 was driven by: strong gold loan growth of ~45% YoY to ~INR1.25t, ~35bp QoQ improvement in GS3 to 2.25%, aided by NPA recoveries, an increase in gold tonnage by ~5% YoY to 209 tons.

Number of FII/FPI investors increased from 750 to 799 in Sep 2025 qtr.

Jubilant Foodworks Ltd.

13 Nov 2025

591.15

-0.67%

Outperformance continues; positive festive commentary

Neutral: Jubilant Foodworks Ltd.

Target

Motilal Oswal

Jubilant FoodWorks (JUBI) reported 16% YoY growth in standalone revenue to INR17b in 2QFY26 (in line). Domino’s reported order growth of 15% with LFL growth of 9%.

Jubilant Foodworks Ltd.'s price crossed below 30Day SMA today

Alkem Laboratories Ltd.

13 Nov 2025

5700.00

-0.42%

Opex from CDMO/Med-tech to constrain margin expansion over the near term

Neutral: Alkem Laboratories Ltd.

Target

Motilal Oswal

ALKEM Laboratories (ALKEM) delivered better-than-expected revenue/EBITDA/PAT, with a beat of 6%/9%/13% for the quarter. The superior performance was driven by broad-based higher revenue growth and lower-than-expected R&D spend for the quarter.

ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6600.0 on 14 Nov, 2025.

Prestige Estates Projects Ltd.

13 Nov 2025

1717.20

-0.01%

Robust 1H launch propels presales beyond FY25 milestone

Buy: Prestige Estates Projects ...

Target

Motilal Oswal

Presales: PEPL reported 50% YoY growth and 50% QoQ decline in presales to INR60.2b (52% beat) in 2QFY26, boosted by stellar launches in NCR and Bengaluru.

Number of FII/FPI investors decreased from 598 to 581 in Sep 2025 qtr

Page Industries Ltd.

13 Nov 2025

38565.00

-0.63%

Uninspiring performance; growth recovery awaited

Buy: Page Industries Ltd.

Target

Motilal Oswal

Page Industries (PAGE) reported muted revenue growth of 4% YoY, with volume growth of 2.5% (est. 4%; 2% in 1QFY26) to 56.6m units.

Page Industries Ltd. has an average target of 44873.20 from 5 brokers.

Ipca Laboratories Ltd.

13 Nov 2025

1438.20

-0.64%

Beat on estimates; DF/API drive earnings

Buy: Ipca Laboratories Ltd.

Target

Motilal Oswal

Ipca Laboratories (IPCA) delivered slightly better-than-expected revenue in 2QFY26, while EBITDA/PAT beat our estimates by 18%/22%.

Number of FII/FPI investors decreased from 270 to 254 in Sep 2025 qtr

Endurance Technologies Ltd.

13 Nov 2025

2752.40

0.57%

Healthy operational performance across segments

Buy: Endurance Technologies Ltd.

Target

Motilal Oswal

Endurance Technologies (ENDU) delivered an in-line operational performance in 2QFY26. PAT miss was largely driven by higher-thanexpected depreciation and a higher tax rate in 2Q.

Endurance Technologies Ltd. is trading above its 200 day SMA of 2429.5

S&P BSE 150 Midcap Index PB	5.2
S&P BSE 150 Midcap Index PE	34.9
S&P BSE 150 Midcap Index DIV	0.8
S&P BSE 150 Midcap Index EPS	474.8